Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption. (2021)
Attributed to:
Design of HIV vaccines that stimulate T cell and NK cell immunity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.abd8179
PubMed Identifier: 33441429
Publication URI: http://europepmc.org/abstract/MED/33441429
Type: Journal Article/Review
Volume: 13
Parent Publication: Science translational medicine
Issue: 576
ISSN: 1946-6234